What AlvaMed does

AlvaMed is a privately held medical device consulting firm founded in 2002 and headquartered in Needham, Massachusetts. It provides regulatory affairs, quality assurance, quality system development, and clinical research services to medical device, combination product, and life sciences companies. The firm organizes its offerings across five interconnected domains — Quality, Clinical, Regulatory, Post-Market/Quality Affairs, and Resource Transformation — comprising more than 30 distinct service lines that range from QMS-in-a-Box and FDA 510(k) submissions to fractional functional leadership, EU MDR clinical evaluation reports, and CRO operations. Customers range from venture-backed startups (Cerevasc, Aseptikits, Eclipse Regenesis, Guard Medical) through mid-market players to large enterprises including Boston Scientific, Pfizer, Teleflex, and Anika Therapeutics.

The firm's underlying technology layer is a proprietary AI-powered audit software platform that conducts automated reviews of quality system documentation — Quality Manuals, SOPs, Forms, and Work Instructions — against FDA, EU MDR, ISO 13485, and other global standards, flagging gaps, inconsistencies, and risks. This platform is integrated into the Audit Program Management service and complements a parallel AI-assisted clinical literature review tool used to accelerate Clinical Evaluation Report creation for EU MDR submissions. AlvaMed also offers an AI Resource Transformation service that helps clients integrate AI into regulated workflows with appropriate validation and governance controls. Services are delivered by approximately 14 named senior consultants and specialists listed on the website, including former FDA reviewers, ISO 13485 Lead Auditors, and SoCRA/CCRA-certified clinical research professionals.

AlvaMed operates as a professional services firm with project-based and retainer engagements, supplemented by an annual US Agent representation fee for foreign manufacturers plus hourly support charges. Pricing is quote-based and not publicly disclosed; engagement scope, device complexity, and level of ongoing support drive total fees. The firm self-reports that 100% of its business is repeat business from existing clients and that 100% of clients rate deliverables and value as excellent. Distribution is entirely direct, with no channel or reseller network; new business is sourced via the firm's website content (insights/blog, case studies, newsletters), an embedded Outlook-based calendar booking tool, client referrals, and senior-consultant outreach. The firm is privately held with no disclosed external funding or institutional investors, and Mark Cox serves as President and Founder.

Name

AlvaMed

Legal name

AlvaMed

Website

https://alvamed.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

AlvaMed is a privately held medical device consulting firm providing regulatory affairs, quality assurance, quality system development, and clinical research services to startups, mid-market firms, and large medtech and life sciences enterprises across North America and Europe.

Ownership category

akta.pro rank

Product category

Medical Device Regulatory and Quality Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Quality Management Systems (QMS) & GxP Documentation (HLAGAKAD)

akta.pro secondary industries

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs) (HLAGAJAI)

Keywords

• Medical device consulting
• Regulatory affairs services
• Quality management systems
• Clinical research services
• FDA compliance services

Headquarters

HQ city

Needham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Professional Consulting Services: AlvaMed generates revenue through consulting fees for regulatory affairs, quality assurance, quality system development, and CRO/clinical management services. Services are delivered by experienced consultants and billed on a project or retainer basis.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

AlvaMed is a consulting and outsourcing firm that helps medical device companies establish, maintain, and remediate Quality Management Systems (QMS), navigate FDA and EU MDR regulatory pathways, run clinical studies through its CRO capabilities, and manage post-market surveillance. Services span QMS in a Box, design assurance, CAPA, internal and supplier auditing, regulatory submissions (510(k), IDE, De Novo, HDE, CE Mark), US Agent representation, and fractional leadership engagements. The firm also deploys a proprietary AI-powered audit software platform to automate reviews of quality system documentation against global regulatory standards.

Product overview

AlvaMed is a consulting firm to the medical device industry offering a comprehensive suite of compliance services. The portfolio spans five interconnected domains: Quality (QMS in a Box, QMS Administration, QMS Harmonization, CAPA Management, Auditing, Design Assurance, Risk Management, Spreadsheet Validation, and Due Diligence); Clinical (CRO Operations, Site Management, Study Monitoring, Clinical Evaluation Reports, and Literature Review); Regulatory Affairs (Device Classification, Strategy, Reimbursement, CE Marking, FDA Submissions including 510(k), IDE, De Novo, and HDE); Post-Market and Quality Affairs (FDA 483 Response, Acquisition Integration, Portfolio Assessment, and Post-market Surveillance); and AI Services (AI Resource Transformation and AI Coaching & Facilitation). This is a service-based consulting model rather than a software platform.

Differentiator

Problem solved

Functional benefit

Products and services

• QMS in a Box A lightweight, flexible Quality Management System solution customizable for small medical device companies requiring compliance with FDA, EU MDR, and ISO 13485 requirements, including rapid deployment and optional ongoing management support.
• QMS Administration Supplementing existing QMS roles to help complete routine QMS administration activities including CAPA responses, management review preparation, and change order processing.
• QMS Harmonization/Integration Consolidating multiple QMSs into a harmonized system for companies expanding internationally, eliminating duplication and adapting to evolving health authority requirements.
• CAPA Program Management Corrective and Preventive Action program implementation ensuring effective risk management through proper root cause determination and management commitment.
• MDSAP Mock Audit and Training Training and mock audits preparing manufacturers for compliance under the Medical Device Single Audit Program covering all five participating jurisdictions.
• Supplier Auditing Risk-based supplier evaluation and audit services to assess supplier capabilities and ensure compliance with manufacturer requirements and quality system standards.
• Internal Auditing Internal audit resourcing including mock audits testing QMS under MDSAP and MDR/IVDR compliance, with strategy development for correcting identified issues.
• Audit Program Management Management of audit programs from annual internal audits to multi-year supply chain auditing agreements, now enhanced with proprietary AI-powered automated documentation review.
• Design Assurance Support Design assurance engineering support covering user needs documentation, product requirements, design verification testing, and risk-based product development guidance.
• Risk Management File Remediation Updating and maintaining comprehensive risk management files to ensure compliance with current ISO 14971 requirements from product development through commercialization.
• DHF/Technical File Remediation Maintaining device design history files and tracking changes following regulatory approval to demonstrate continued regulatory compliance and inspection readiness.
• Fractional Leadership Part-time senior regulatory, quality, clinical, and management representative leadership for companies lacking full-time resources in these functional areas.
• FDA 483 Remediation Response Comprehensive support navigating FDA 483 response process including observation analysis, CAPA plan development, timeline establishment, and FDA communication.
• Due Diligence Support Evaluating acquisition targets through regulatory, quality, and clinical due diligence to assess pros and cons and understand compliance challenges.
• Acquisition Integration Quality system integration services for harmonizing acquired companies into enterprise QMS, including regulatory risk assessment and portfolio planning.
• CRO and Clinical Operations Full-service clinical research organization capabilities including study design, site management, monitoring, safety management, and trial master file oversight.
• Clinical Site Management Bridging sponsor-clinician research gaps by hiring and managing research staff, connecting sponsors with clinicians, and providing site study support.
• Clinical Study Monitoring Site-level study monitoring and oversight with accredited monitors possessing SOCRA, CCRA and other agency accreditations, available as standalone or integrated with CRO services.
• Clinical Evaluation Reports – EU MDR Clinical evaluation report creation for EU MDR compliance including device classification, clinical data review, CEP creation, literature review, and PMCF plan development.
• Clinical Literature Review Systematic literature search and review for clinical evaluation, regulatory submissions, and post-market surveillance using proprietary assistive AI tools for efficient data extraction.
• FDA 510(k) Submissions 510(k) premarket notification submission support with proven first-attempt success record, including predicate device identification, testing requirements, and eSTAR template preparation.
• De Novo and HDE Submissions FDA De Novo, PMA Supplements, Humanitarian Use Device (HDE), Breakthrough Devices Program, and Emergency Use Authorization submission support.
• FDA IDE Submissions Investigational Device Exemption submission support including benchmark analysis, regulatory pathway definition, strategy planning, and FDA Pre-Submission guidance.
• CE Marking Submissions EU regulatory process support for obtaining CE marking including conformity assessment route selection, quality system implementation, technical data preparation, and Declaration of Conformity.
• US Agent Services FDA US Agent representation for foreign manufacturers including FDA communication liaison, inspection scheduling assistance, and device/company registration.
• Device Classification Evaluation FDA device classification evaluation determining appropriate regulatory pathway and device class (I, II, III) based on risk assessment factors.
• Regulatory Strategy and Planning Strategic regulatory direction balancing regulatory risk with business goals across cardiovascular, orthopedic, SaMD, and therapeutic devices.
• Reimbursement Strategic reimbursement planning including landscape assessment, clinical data strategy, coding analysis, payer advocacy, and CPT code application support.
• Post-market Program Management Feedback process implementation for post-market surveillance including complaint handling, proactive feedback collection, data analysis, and risk-based action implementation.
• AI Resource Transformation Responsible AI integration into regulated workflows to rebalance workloads and improve efficiency while maintaining expert-validated results for medical device and life science organizations.

Quantifiable outcome

• 100% of business is repeat business from existing clients
• +3 more outcomes

Named customers14 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature1 record

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• RQM+: RQM+ is a medical device consulting firm offering regulatory, quality, and clinical services directly overlapping AlvaMed's QMS, RA, and clinical evaluation practices. Comparable because both monetize senior regulatory expertise for medtech companies navigating FDA and EU MDR pathways.
• The FDA Group: The FDA Group provides regulatory, quality, and compliance consulting, including former FDA staff, mirroring AlvaMed's talent moat and service mix. Both target medtech manufacturers needing rapid remediation, QMS setup, and submission support.
• MedTech Regulatory Solutions (MTRS): Smaller RA/QA consultancy focused on quality systems, 510(k) and CE Mark submissions for medtech startups. Overlaps with AlvaMed's core offerings to small and mid-size medtech companies.
• SQA Services / Compliance Group: SQA Services is a quality and regulatory consulting firm providing QMS implementation, audits, and supplier auditing for medical device manufacturers. Direct overlap with AlvaMed's quality auditing, CAPA, and QMS remediation services.
• Criterion Edge: Criterion Edge provides clinical evaluation reports, literature reviews, and EU MDR post-market surveillance support for medical device companies. Directly comparable to AlvaMed's CER and Clinical Literature Review offerings.
• Regulatory Technology Solutions (RTS): RTS provides regulatory affairs consulting and software solutions (e.g., eCTD, publishing) for life sciences including medical devices. Comparable in regulatory services to AlvaMed, with additional software tooling.

Broad incumbents

• NAMSA: NAMSA is a global medical device CRO and consulting firm spanning regulatory strategy, clinical research, and laboratory services. Larger and broader than AlvaMed, with overlapping medtech regulatory and clinical operations offerings.
• Veranex: Veranex is an integrated medtech services provider spanning design, regulatory, quality, and clinical. Competes with AlvaMed on regulatory strategy, QMS, and clinical affairs for medtech clients, though at a much larger scale.

Emerging players

• Greenlight Guru: Greenlight Guru provides eQMS software purpose-built for medical device QMS and ISO 13485 compliance. An emerging software peer that complements (and could compete with) the consulting-led QMS services AlvaMed delivers.

Others

• BSI Group (Notified Body): BSI is a Notified Body and standards body whose CE Marking and ISO 13485 certification activities shape the regulatory environment AlvaMed helps clients navigate. Adjacent/ecosystem participant rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alvamed

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlvaMed